Braizon Therapeutics Revenue

Biotechnology Research • 3 Chome-42-1 Hongo, Bunkyo-ku, Japan • 1-10 Employees

Braizon Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	$9,500,000

Key Contact at Braizon Therapeutics

Mariko Tosu

Founder and Chairperson

Company overview

Headquarters	3 Chome-42-1 Hongo, Bunkyo-ku, 201, Tokyo, Tokyo 113-0033, JP
Phone number	+81358053417
Website	braizon.com
NAICS	541714
Keywords	Biotechnology, Nanomedicine, Drug Delivery System, Blood Brain Barrier
Founded	2015
Employees	1-10
Socials

Braizon Therapeutics Email Formats

Braizon Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@braizon.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@braizon.com	100%

About Braizon Therapeutics

Braizon Therapeutics, Inc. is working to solve the blood brain barrier problem for oligonucleotide therapeutics, removing the need for spinal cord injections to treat neurological disorders. Our Brain Access platform utilizes novel IP combining polymer nanoparticles with proven targeting methods for targeting therapies to the brain to create IV formulations for our partners. This platform is under development for expansion into small molecule, peptide, and antibody drug delivery into the brain. HQ'd in Tokyo, Braizon has US operations in Cambridge, MA. enabling our experienced team to offer partnering worldwide for biotech and Pharma with a strategic focus on neurology.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Braizon Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Braizon Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-08-09	5	$9,500,000

Funding Insights

$9,500,000

Total funding amount

$9,500,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Braizon Therapeutics is located in 3 Chome-42-1 Hongo, Bunkyo-ku, JP.

You can reach Braizon Therapeutics at +81358053417.

Braizon Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Braizon Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Braizon Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Braizon Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Braizon Therapeutics has raised a total of $9,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Braizon Therapeutics

Mariko Tosu

Founder and Chairperson

4.8

40,000 users